Top Markets
#1 Palladium Network Palladium Network +27.89%
#2 Ankr Network Ankr Network +10.42%
#3 Status Status +8.22%
#4 would would +6.86%
#5 Hive Hive +6.25%
#6 WAX WAX +5.69%
#7 Pons Pons +4.94%
#8 The Bitcoin Bull The Bitcoin Bull +4.43%
#9 OpenAI (Republic Pre-IPO) OpenAI (Republic Pre-IPO) +4.16%
#10 edgeX edgeX +3.72%
Coin of the day
Palladium Network Palladium Network
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
Rang in Aktien #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
Aktienkurs
$5.84
Zuletzt synchronisiert: 2025-04-02
Marktkapitalisierung
$224.09M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Nevro Corp. (NVRO)

Kategorie

Healthcare
Operative Marge für Nevro Corp. (NVRO)
Operative Marge zum September 2026 TTM: -30.90%
Laut den neuesten Finanzberichten und dem Aktienkurs von Nevro Corp. beträgt die aktuelle operative Marge (TTM) -30.90%. Am Ende des Jahres 2023 lag die operative Marge bei -23.36%.
Historie der operativen Marge von Nevro Corp. von 2012 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) -30.90% 0.00%
2024 -30.90% 32.28%
2023 -23.36% -3.95%
2022 -24.32% 3.49%
2021 -23.50% 35.37%
2020 -17.36% -29.77%
2019 -24.72% 129.31%
2018 -10.78% 19.12%
2017 -9.05% -10.40%
2016 -10.10% -88.73%
2015 -89.60% 3.11%
2014 -86.90% -18.81%
2013 -107.03% 1.55%
2012 -105.40% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -100.55%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -100.71%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -100.58%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -100.69%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
28.09% -100.91%
US
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.